New Macrocyclic Drug Templates That Mimic Protein Structures for Antiviral Applications
Novel macrocyclic amino acids that lock peptides into beta-strand conformations were developed as protease inhibitor templates, with applications in antiviral drug design against HIV and HCV.
Quick Facts
What This Study Found
Novel macrocyclic amino acids that constrain peptides into beta-strand conformations were developed as protease inhibitor templates, showing application in antiviral drug design against HIV and HCV proteases.
Key Numbers
How They Did This
In-vitro medicinal chemistry study. Macrocyclic amino acids designed, synthesized, and incorporated into protease inhibitor scaffolds. Tested against viral proteases.
Why This Research Matters
Converting flexible peptides into rigid macrocyclic drugs improves their potency, selectivity, and oral bioavailability — key challenges in antiviral peptide drug development.
The Bigger Picture
Macrocyclic drug design is one of pharmaceutical chemistry's most productive strategies for creating peptide-inspired drugs. These building blocks expand the toolkit for targeting viral and other proteases.
What This Study Doesn't Tell Us
In-vitro design and testing. In-vivo pharmacology not demonstrated. The specific potency against viral proteases was not detailed.
Questions This Raises
- ?Can these macrocyclic templates achieve oral bioavailability?
- ?How do they compare to existing protease inhibitors?
- ?Could the approach be applied to other protease-driven diseases?
Trust & Context
- Key Stat:
- Shape-locked drugs Macrocyclic constraints force peptides into the exact beta-strand shape needed for potent protease inhibition — precision drug engineering
- Evidence Grade:
- Preliminary medicinal chemistry evidence with novel building block design and protease targeting, limited by early-stage development.
- Study Age:
- Published in 2002. Macrocyclic protease inhibitors have become mainstream in drug design, with several macrocyclic drugs now approved for HIV and HCV.
- Original Title:
- Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.
- Published In:
- Journal of medicinal chemistry, 45(2), 371-81 (2002)
- Authors:
- Glenn, Matthew P, Pattenden, Leonard K, Reid, Robert C, Tyssen, David P, Tyndall, Joel D A, Birch, Christopher J, Fairlie, David P
- Database ID:
- RPEP-00730
Evidence Hierarchy
Frequently Asked Questions
What are macrocyclic drugs?
Drugs with ring-shaped molecular structures that lock the molecule into the ideal shape for binding its target. This rigidity makes them more potent and stable than their flexible counterparts.
Are these used for viral infections?
Yes, this approach has been validated. Several approved antiviral drugs now use macrocyclic structures to inhibit viral proteases, including treatments for HIV and hepatitis C.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00730APA
Glenn, Matthew P; Pattenden, Leonard K; Reid, Robert C; Tyssen, David P; Tyndall, Joel D A; Birch, Christopher J; Fairlie, David P. (2002). Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.. Journal of medicinal chemistry, 45(2), 371-81.
MLA
Glenn, Matthew P, et al. "Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.." Journal of medicinal chemistry, 2002.
RethinkPeptides
RethinkPeptides Research Database. "Beta-strand mimicking macrocyclic amino acids: templates for..." RPEP-00730. Retrieved from https://rethinkpeptides.com/research/glenn-2002-betastrand-mimicking-macrocyclic-amino
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.